Table of Contents Author Guidelines Submit a Manuscript
Stroke Research and Treatment
Volume 2016, Article ID 9706720, 12 pages
http://dx.doi.org/10.1155/2016/9706720
Research Article

Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials

1Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham NG5 1PB, UK
2Neurological & Mental Health Division, University of Sydney, Sydney, NSW 2000, Australia
3Department of Internal Medicine, Oslo University Hospital, 0424 Oslo, Norway
4Oxford Academic Health Sciences Network, Oxford University Hospitals, NHS Trust, Oxford OX4 4GA, UK
5Department of Cardiovascular Sciences and NIHR Biomedical Research Unit for Cardiovascular Disease, University of Leicester, Leicester LE3 9QP, UK
6Geffen School of Medicine at UCLA, UCLA Comprehensive Stroke Center, Los Angeles, CA 90095, USA
7Division of Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
8University of Nottingham, Nottingham NG5 1PB, UK

Received 20 November 2015; Accepted 14 January 2016

Academic Editor: David Vaudry

Copyright © 2016 Philip M. Bath et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Emberson, K. R. Lees, P. Lyden et al., “Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials,” The Lancet, vol. 384, no. 9958, pp. 1929–1935, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Wardlaw, V. Murray, E. Berge, and G. J. del Zoppo, “Thrombolysis for acute ischaemic stroke,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD000213, 2009. View at Google Scholar · View at Scopus
  3. O. A. Berkhemer, P. S. S. Fransen, D. Beumer et al., “A randomized trial of intraarterial treatment for acute ischemic stroke,” The New England Journal of Medicine, vol. 372, no. 1, pp. 11–20, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. B. C. V. Campbell, P. J. Mitchell, T. J. Kleinig et al., “Endovascular therapy for ischemic stroke with perfusion-imaging selection,” The New England Journal of Medicine, vol. 372, no. 11, pp. 1109–1018, 2015. View at Publisher · View at Google Scholar
  5. M. Goyal, A. M. Demchuk, B. K. Menon et al., “Randomized assessment of rapid endovascular treatment of ischemic stroke,” The New England Journal of Medicine, vol. 372, no. 11, pp. 1019–1030, 2015. View at Publisher · View at Google Scholar
  6. K. Vahedi, J. Hofmeijer, E. Juettler et al., “Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials,” The Lancet Neurology, vol. 6, no. 3, pp. 215–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. P. A. G. Sandercock, C. Counsell, G. J. Gubitz, and M.-C. Tseng, “Antiplatelet therapy for acute ischaemic stroke,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD000029, 2008. View at Google Scholar · View at Scopus
  8. Stroke Unit Trialists' Collaboration, “Organised inpatient (stroke unit) care for stroke,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD000197, 2007. View at Publisher · View at Google Scholar
  9. C. S. Anderson, E. Heeley, Y. Huang et al., “Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage,” The New England Journal of Medicine, vol. 368, no. 25, pp. 2355–2365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Hemphill, S. M. Greenberg, C. S. Anderson et al., “Guidelines for the management of spontaneous intracerebral hemorrhage,” Stroke, vol. 46, no. 7, pp. 2032–2060, 2015. View at Publisher · View at Google Scholar
  11. R. M. J. Palmer, A. G. Ferrige, and S. Moncada, “Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor,” Nature, vol. 327, no. 6122, pp. 524–526, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. M. W. Radomski, R. M. J. Palmer, and S. Moncada, “The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium,” Biochemical and Biophysical Research Communications, vol. 148, no. 3, pp. 1482–1489, 1987. View at Publisher · View at Google Scholar · View at Scopus
  13. R. G. Knowles, M. Palacios, R. M. J. Palmer, and S. Moncada, “Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 13, pp. 5159–5162, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. D. D. Rees, R. M. J. Palmer, and S. Moncada, “Role of endothelium-derived nitric oxide in the regulation of blood pressure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 9, pp. 3375–3378, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ferlito, M. Gallina, G. M. Pitari, and A. Bianchi, “Nitric oxide plasma levels in patients with chronic and acute cerebrovascular disorders,” Panminerva Medica, vol. 40, no. 1, pp. 51–54, 1998. View at Google Scholar · View at Scopus
  16. P. A. Rashid, A. Whitehurst, N. Lawson, and P. M. W. Bath, “Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome,” Journal of Stroke and Cerebrovascular Diseases, vol. 12, no. 2, pp. 82–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Willmot, L. Gray, C. Gibson, S. Murphy, and P. M. W. Bath, “A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow,” Nitric Oxide—Biology and Chemistry, vol. 12, no. 3, pp. 141–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Garry, M. Ezra, M. J. Rowland, J. Westbrook, and K. T. S. Pattinson, “The role of the nitric oxide pathway in brain injury and its treatment—from bench to bedside,” Experimental Neurology, vol. 263, pp. 235–243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. R. J. Butterworth, A. Cluckie, S. H. D. Jackson, M. Buxton-Thomas, and P. M. W. Bath, “Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke,” Cerebrovascular Diseases, vol. 8, no. 3, pp. 158–165, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Ankolekar, M. Fuller, I. Cross et al., “Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in hypertensive stroke trial (RIGHT, ISRCTN66434824),” Stroke, vol. 44, no. 11, pp. 3120–3128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. P. M. W. Bath, L. Woodhouse, P. Scutt et al., “Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial,” The Lancet, vol. 385, no. 9968, pp. 617–628, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Geeganage and P. M. Bath, “Vasoactive drugs for acute stroke,” Cochrane Database of Systematic Reviews, vol. 7, Article ID CD002839, 2010. View at Google Scholar · View at Scopus
  23. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, The Cochrane Collaboration, 2011.
  24. J. Bamford, P. Sandercock, M. Dennis, J. Burn, and C. Warlow, “Classification and natural history of clinically identifiable subtypes of cerebral infarction,” The Lancet, vol. 337, no. 8756, pp. 1521–1526, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. P. M. W. Bath, R. Pathansali, R. Iddenden, and F. J. Bath, “The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke,” Cerebrovascular Diseases, vol. 11, no. 3, pp. 265–272, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Rashid, C. Weaver, J. Leonardi-Bee, F. Bath, S. Fletcher, and P. Bath, “The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 12, no. 3, pp. 143–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Willmot, A. Ghadami, B. Whysall, W. Clarke, J. Wardlaw, and P. M. W. Bath, “Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke,” Hypertension, vol. 47, no. 6, pp. 1209–1215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, “Tissue plasminogen activator for acute ischemic stroke,” The New England Journal of Medicine, vol. 333, no. 24, pp. 1581–1587, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Leonardi-Bee, P. M. W. Bath, S. J. Phillips, and P. A. G. Sandercock, “Blood pressure and clinical outcomes in the International Stroke Trial,” Stroke, vol. 33, no. 5, pp. 1315–1320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. C. S. Anderson, Y. Huang, J. G. Wang et al. et al., “Intensive blood pressure reduction in actue cerebral haemorrhage trial (interact): a randomised pilot trial,” Lancet Neurology, vol. 7, no. 5, pp. 391–399, 2008. View at Publisher · View at Google Scholar
  31. E. Morikawa, S. Rosenblatt, and M. A. Moskowitz, “L-arginine dilates rat pial arterioles by nitric oxide-dependent mechanisms and increases blood flow during focal cerebral ischaemia,” British Journal of Pharmacology, vol. 107, no. 4, pp. 905–907, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Zhang, J. G. White, and C. Iadecola, “Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 14, no. 2, pp. 217–226, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. J. B. Salom, M. Ortí, J. M. Centeno, G. Torregrosa, and E. Alborch, “Reduction of infarct size by the NO donors sodium nitroprusside and spermine/NO after transient focal cerebral ischemia in rats,” Brain Research, vol. 865, no. 2, pp. 149–156, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Khan, M. Jatana, C. Elango, A. Singh Paintlia, A. K. Singh, and I. Singh, “Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke,” Nitric Oxide, vol. 15, no. 2, pp. 114–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Zhuang, H. Ji, Y.-H. Zhang, Z.-L. Min, Q.-G. Ni, and R. You, “ZJM-289, a novel nitric oxide donor, alleviates the cerebral ischaemic–reperfusion injury in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 37, no. 3, pp. e121–e127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. J. Clarke and L. A. Stewart, “Systematic Reviews: Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses?” British Medical Journal, vol. 309, pp. 1007–1010, 1994. View at Publisher · View at Google Scholar
  37. K. R. Lees, E. Bluhmki, R. von Kummer et al., “Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials,” The Lancet, vol. 375, no. 9727, pp. 1695–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. H. M. den Hertog, H. B. van der Worp, H. M. A. van Gemert et al., “The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial,” The Lancet Neurology, vol. 8, no. 5, pp. 434–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. K. D. Hougaard, N. Hjort, D. Zeidler et al., “Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial,” Stroke, vol. 45, no. 1, pp. 159–167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Woodhouse, P. Scutt, K. Krishnan et al., “Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial,” Stroke, vol. 46, pp. 3194–3201, 2015. View at Publisher · View at Google Scholar
  41. “Miocardio GIplsdSni. Gissi-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction,” The Lancet, vol. 343, no. 8906, pp. 1115–1122, 1994.
  42. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group, “ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction,” The Lancet, vol. 345, no. 8951, pp. 669–685, 1995. View at Publisher · View at Google Scholar
  43. F. J. Bath and P. M. W. Bath, “What is the correct management of blood pressure in acute stroke? The blood pressure in acute stroke collaboration,” Cerebrovascular Diseases, vol. 7, no. 4, pp. 205–213, 1997. View at Publisher · View at Google Scholar · View at Scopus